Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex.
Himika WasanDevendra SinghBalu JoshiDeepti UpadhyayUma SharmaAmit Kumar DindaK H ReetaPublished in: Neurological research (2021)
This study demonstrated the efficacy of subacute DHM treatment in ischemia/reperfusion injury by modulating apoptosis and astrogliosis in the peri-infarct cortex. This suggests the potential of DHM in attenuating disease progression.
Keyphrases
- endoplasmic reticulum stress
- oxidative stress
- cell cycle arrest
- acute myocardial infarction
- functional connectivity
- cell death
- subarachnoid hemorrhage
- signaling pathway
- mouse model
- heart failure
- risk assessment
- pi k akt
- acute coronary syndrome
- combination therapy
- coronary artery disease
- human health
- left ventricular
- climate change
- cerebral ischemia